HEScGRO embryonic stem cell medium will be available by end of year.
Millipore will develop and market Stem Cell Sciences’ (SCS) serum-free media for the growth of human embryonic stem cells (HESC), according to an exclusive license deal between the two firms.

“We chose SCS because their media worked extremely well in growing hESCs in a variety of different stem cell lines and conditions and they had the most advanced development of serum-free media,” explains Dominique Baly, president of Millipore’s bioscience division.

Under the terms of the agreement, Millipore will manufacture, market, and sell the new media under the brand name HEScGRO Embryonic Stem Cell Medium. SCS will receive royalties from all future sales of HEScGRO Embryonic Stem Cell Medium.

Previous articleLaureate Pharma Will Continue to Manufacture Cytogen’s ProstaScint
Next articleAchaogen Awarded $24.7M for Anthrax and Plague